Breaking Barriers: Facilitating FDA Approval
Morula Health developed a first‑in‑human Phase 1 protocol for an FDA IND submission within five weeks. By combining regulatory insight with immuno‑oncology expertise, our team helped the client meet critical timelines and advance their program toward approval.
Find out more